SRNE logo

Sorrento Therapeutics (SRNE) Depreciation And Amortization

Annual D&A

$13.24 M
+$783.00 K+6.28%

December 31, 2022

Summary

Performance

1-Year Change

+6.28%

3-Year Change

+20.53%

5-Year Change

+85.56%

15-Year Change

+85.56%

SRNE Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.15%
SRNE annual depreciation & amortization is higher than 74.15% of companies in Healthcare sector

High & Low

All-time High

$13.24 M
SRNE annual depreciation & amortization is currently at an all-time high

3-Year Low

$12.46 M
SRNE annual depreciation & amortization is currently +6.28% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
SRNE previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

May 15, 2025
SRNE next annual earnings announcement is scheduled for May 15, 2025

Related metrics

Annual Total Expenses

$441.34 M
SRNE annual total expenses is $441.34 million

Annual Operating Expenses

$407.89 M
SRNE annual total operating expenses is $407.89 million

Annual Cost Of Goods Sold

$33.45 M
SRNE annual cost of goods sold is $33.45 million

Annual Interest Expense

$8.57 M
SRNE annual interest expense is $8.57 million

Quarterly D&A

$3.59 M
-$30.00 K-0.83%

June 30, 2023

Summary

Performance

3-Month Change

-0.83%

1-Year Change

-0.83%

3-Year Change

-0.83%

5-Year Change

-0.83%

SRNE Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.6%
SRNE quarterly depreciation & amortization is higher than 74.6% of companies in Healthcare sector

High & Low

All-time High

$3.62 M
SRNE quarterly depreciation & amortization is currently -0.83% below its historical high of $3.62 million

3-Year Low

$2.86 M
SRNE quarterly depreciation & amortization is currently +25.67% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
SRNE previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

May 15, 2025
SRNE next earnings announcement is scheduled for May 15, 2025

Related metrics

Quarterly Total Expenses

$91.79 M
SRNE quarterly total expenses is $91.79 million

Quarterly Operating Expenses

$83.34 M
SRNE quarterly total operating expenses is $83.34 million

Quarterly Cost Of Goods Sold

$8.45 M
SRNE quarterly cost of goods sold is $8.45 million

Quarterly Interest Expense

$2.67 M
SRNE quarterly interest expense is $2.67 million

TTM D&A

$13.93 M
+$357.00 K+2.63%

June 30, 2023

Summary

Performance

3-Month Change

+2.63%

1-Year Change

+2.63%

3-Year Change

+2.63%

5-Year Change

+2.63%

SRNE TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.04%
SRNE TTM depreciation & amortization is higher than 74.04% of companies in Healthcare sector

High & Low

All-time High

$13.93 M
SRNE TTM depreciation & amortization is currently at an all-time high

3-Year Low

$12.46 M
SRNE TTM depreciation & amortization is currently +11.76% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
SRNE previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

May 15, 2025
SRNE next earnings announcement is scheduled for May 15, 2025

Related metrics

Annual Total Expenses

$441.34 M
SRNE annual total expenses is $441.34 million

Annual Operating Expenses

$407.89 M
SRNE annual total operating expenses is $407.89 million

TTM Cost Of Goods Sold

$35.63 M
SRNE TTM cost of goods sold is $35.63 million

TTM Interest Expense

$6.81 M
SRNE TTM interest expense is $6.81 million

SRNE Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.3%-0.8%+2.6%
3 y3 years+20.5%-0.8%+2.6%
5 y5 years+85.6%-0.8%+2.6%

SRNE Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+6.3%-0.8%+25.7%at high+11.8%
5 y5-yearat high+20.5%-0.8%+62.1%at high+31.7%
alltimeall timeat high>+9999.0%-0.8%>+9999.0%at high>+9999.0%

Sorrento Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Jun 2023
-
$3.59 M(-0.8%)
$13.93 M(+2.6%)
Mar 2023
-
$3.62 M(+8.1%)
$13.57 M(+2.5%)
Dec 2022
$13.24 M(+6.3%)
$3.35 M(-0.1%)
$13.24 M(+3.9%)
Sep 2022
-
$3.36 M(+3.8%)
$12.75 M(-1.5%)
Jun 2022
-
$3.24 M(-1.9%)
$12.94 M(+0.8%)
Mar 2022
-
$3.30 M(+15.4%)
$12.84 M(+3.0%)
Dec 2021
$12.46 M(+13.2%)
$2.86 M(-19.4%)
$12.46 M(+5.4%)
Sep 2021
-
$3.55 M(+13.0%)
$11.82 M(+3.6%)
Jun 2021
-
$3.14 M(+7.5%)
$11.41 M(+5.0%)
Mar 2021
-
$2.92 M(+31.6%)
$10.87 M(-1.3%)
Dec 2020
$11.01 M(+0.2%)
$2.22 M(-29.3%)
$11.01 M(-4.5%)
Sep 2020
-
$3.14 M(+20.9%)
$11.53 M(+7.7%)
Jun 2020
-
$2.60 M(-15.1%)
$10.71 M(+1.2%)
Mar 2020
-
$3.06 M(+11.6%)
$10.58 M(-3.8%)
Dec 2019
$10.99 M(+15.7%)
$2.74 M(+18.5%)
$10.99 M(-4.9%)
Sep 2019
-
$2.31 M(-6.0%)
$11.55 M(+0.5%)
Jun 2019
-
$2.46 M(-29.0%)
$11.50 M(+4.9%)
Mar 2019
-
$3.47 M(+5.1%)
$10.96 M(+15.4%)
Dec 2018
$9.49 M(+33.0%)
$3.30 M(+46.0%)
$9.49 M(+17.8%)
Sep 2018
-
$2.26 M(+17.4%)
$8.06 M(+2.3%)
Jun 2018
-
$1.93 M(-3.9%)
$7.88 M(+2.5%)
Mar 2018
-
$2.00 M(+7.4%)
$7.69 M(+7.7%)
Dec 2017
$7.14 M(+147.4%)
$1.87 M(-10.4%)
$7.14 M(+3.0%)
Sep 2017
-
$2.08 M(+20.1%)
$6.93 M(+39.4%)
Jun 2017
-
$1.73 M(+19.3%)
$4.97 M(+31.0%)
Mar 2017
-
$1.45 M(-12.5%)
$3.79 M(+31.5%)
Dec 2016
$2.88 M
$1.66 M(+1262.3%)
$2.88 M(+64.3%)
DateAnnualQuarterlyTTM
Sep 2016
-
$122.00 K(-78.1%)
$1.76 M(-14.1%)
Jun 2016
-
$556.00 K(+2.0%)
$2.04 M(-2.3%)
Mar 2016
-
$545.00 K(+2.3%)
$2.09 M(-11.7%)
Dec 2015
$2.37 M(-25.6%)
$533.00 K(+30.0%)
$2.37 M(-10.5%)
Sep 2015
-
$410.00 K(-32.1%)
$2.65 M(-13.0%)
Jun 2015
-
$604.00 K(-26.6%)
$3.04 M(-5.8%)
Mar 2015
-
$823.00 K(+1.4%)
$3.23 M(+1.5%)
Dec 2014
$3.18 M(+146.8%)
$812.00 K(+0.9%)
$3.18 M(+5.3%)
Sep 2014
-
$805.00 K(+1.5%)
$3.02 M(+19.6%)
Jun 2014
-
$793.00 K(+2.5%)
$2.53 M(+28.9%)
Mar 2014
-
$774.00 K(+18.7%)
$1.96 M(+52.0%)
Dec 2013
$1.29 M(+340.3%)
$652.00 K(+111.0%)
$1.29 M(+78.7%)
Sep 2013
-
$309.00 K(+36.7%)
$722.00 K(+47.3%)
Jun 2013
-
$226.00 K(+119.4%)
$490.10 K(+47.0%)
Mar 2013
-
$103.00 K(+22.6%)
$333.50 K(+13.8%)
Dec 2012
$293.00 K(+84.0%)
$84.00 K(+8.9%)
$293.00 K(+10.9%)
Sep 2012
-
$77.10 K(+11.1%)
$264.20 K(+12.9%)
Jun 2012
-
$69.40 K(+11.0%)
$234.10 K(+12.4%)
Mar 2012
-
$62.50 K(+13.2%)
$208.30 K(+30.8%)
Dec 2011
$159.20 K(+580.3%)
$55.20 K(+17.4%)
$159.20 K(+44.1%)
Sep 2011
-
$47.00 K(+7.8%)
$110.50 K(+57.9%)
Jun 2011
-
$43.60 K(+225.4%)
$70.00 K(+114.1%)
Mar 2011
-
$13.40 K(+106.2%)
$32.70 K(+39.1%)
Dec 2010
$23.40 K(+735.7%)
$6500.00(0.0%)
$23.50 K(+38.2%)
Sep 2010
-
$6500.00(+3.2%)
$17.00 K(+61.9%)
Jun 2010
-
$6300.00(+50.0%)
$10.50 K(+150.0%)
Mar 2010
-
$4200.00
$4200.00
Dec 2009
$2800.00
-
-

FAQ

  • What is Sorrento Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Sorrento Therapeutics?
  • What is Sorrento Therapeutics annual D&A year-on-year change?
  • What is Sorrento Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Sorrento Therapeutics?
  • What is Sorrento Therapeutics quarterly D&A year-on-year change?
  • What is Sorrento Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Sorrento Therapeutics?
  • What is Sorrento Therapeutics TTM D&A year-on-year change?

What is Sorrento Therapeutics annual depreciation & amortization?

The current annual D&A of SRNE is $13.24 M

What is the all time high annual D&A for Sorrento Therapeutics?

Sorrento Therapeutics all-time high annual depreciation & amortization is $13.24 M

What is Sorrento Therapeutics annual D&A year-on-year change?

Over the past year, SRNE annual depreciation & amortization has changed by +$783.00 K (+6.28%)

What is Sorrento Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of SRNE is $3.59 M

What is the all time high quarterly D&A for Sorrento Therapeutics?

Sorrento Therapeutics all-time high quarterly depreciation & amortization is $3.62 M

What is Sorrento Therapeutics quarterly D&A year-on-year change?

Over the past year, SRNE quarterly depreciation & amortization has changed by -$30.00 K (-0.83%)

What is Sorrento Therapeutics TTM depreciation & amortization?

The current TTM D&A of SRNE is $13.93 M

What is the all time high TTM D&A for Sorrento Therapeutics?

Sorrento Therapeutics all-time high TTM depreciation & amortization is $13.93 M

What is Sorrento Therapeutics TTM D&A year-on-year change?

Over the past year, SRNE TTM depreciation & amortization has changed by +$357.00 K (+2.63%)